Preclinical evaluations of Norcantharidin liposome and emulsion hybrid delivery system with improved encapsulation efficiency and enhanced antitumor activity-Reference-Cited by-同舟云学术

Preclinical evaluations of Norcantharidin liposome and emulsion hybrid delivery system with improved encapsulation efficiency and enhanced antitumor activity

Published:2022-04-03 Issue:4 Volume:19 Page:451-464
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Liu Zixu¹,Zhao Linxuan²,Tan Xinyi¹,Wu Zixuan¹,Zhou Ning¹,Dong Nan¹,Zhang Yu¹^ORCID,Yin Tian³,He Haibing¹,Gou Jingxin¹,Tang Xing¹,Gao Song⁴

Affiliation:

1. Department of Pharmaceutics Science, Shenyang Pharmaceutical University, Shenyang, China

2. Department of Pharmaceutics, College of Pharmacy Sciences, Jilin University, Changchun, China

3. School of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang,China

4. Department of Oncology, Shengjing Hospital of China Medical University, Shenyang,China

Funder

National Mega-project for Innovative Drugs

Liaoning Revitalization Talents Program

National Science and Technology Major Project of the Ministry of Science and Technology of China

Special Translational Project for Medical Scientific and Technological Achievements of Liaoning Province, 345 Talent Project, Shengjing Hospital of China Medical University

Liaoning Livelihood Science and Technology Plan Joint Project

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2022.2063834

Reference75 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis

3. Immune Checkpoint Inhibitors in the Treatment of HCC

4. Doxorubicin intercalated copper diethyldithiocarbamate functionalized layered double hydroxide hybrid nanoparticles for targeted therapy of hepatocellular carcinoma

5. Preparation and pharmacological evaluation of norcantharidin-conjugated carboxymethyl chitosan in mice bearing hepatocellular carcinoma

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of carboxymethylcellulose-conjugated polymeric prodrug micelles for enhanced in vivo performance of docetaxel;International Journal of Biological Macromolecules;2023-12

2. Intratumoral injection of norcantharidin liposome emulsion hybrid delivery system amplifies the cancer-fighting effects of oral sorafenib against hepatocellular carcinoma;Colloids and Surfaces B: Biointerfaces;2023-12

3. The self-adjuvant heterocyclic lipid nanoparticles encapsulated with vaccine and STAT3 siRNA boost cancer immunotherapy through DLN-targeted and STING pathway;Chemical Engineering Journal;2023-11

4. Influence of Auricularia cornea Polysaccharide Coating on the Stability and Antioxidant Activity of Liposomes Ginsenoside Rh2;Foods;2023-10-29

5. Liposomal Nanodrug Based on Norcantharidin Derivative for Increased in Vivo Activity;AAPS PharmSciTech;2023-05-10